N.Y. Study Shows Treatment With Hydroxychloroquine Did Not Significantly Improve Mortality Among Seriously Ill COVID-19 Patient
May 14, 2020
May 14, 2020
BROOKLYN, New York, May 14 -- Downstate Medical Center issued the following news release:
Results of an observational study of the use hydroxychloroquine, azithromycin, or both, for the treatment of COVID-19, was not associated with significantly improved in-hospital mortality. The study was published online on Monday, May 11, by the Journal of the American Medical Association.
"Unfortunately, we did not observe benefits of the most used drug (hydroxychloroquine wi . . .
Results of an observational study of the use hydroxychloroquine, azithromycin, or both, for the treatment of COVID-19, was not associated with significantly improved in-hospital mortality. The study was published online on Monday, May 11, by the Journal of the American Medical Association.
"Unfortunately, we did not observe benefits of the most used drug (hydroxychloroquine wi . . .